Australian Society for Antimicrobials
PO Box 8266 Angelo St, South Perth, Western Australia 6151
Fax: 61 8 9450 8553, Email: info@asainc.net.au, Twitter: @AusAntibiotics
Login:
Password:
 

Welcome to the web site of the Australian Society for Antimicrobials.

Since becoming an Incorporated Society in March 1999, ASA membership now covers a diverse background of professions interested in the study of antimicrobials including clinical microbiologists and infectious diseases physicians, respiratory and ICU physicians, medical and non-medical microbiologists and scientists, pharmacists, veterinarians, undergraduate and postgraduate students, and industry representatives from pharmaceutical and diagnostic/research biomedical companies.
On this site you can access the Society's Objectives, Constitution and the Committee Members.
The Society's Membership Subscription Form and details of the Annual Scientific Meeting can be downloaded.
Members of the Society can download current and previous newsletters, as well as abstracts from previous annual scientific meetings, in the Members Area.
Although ASA's membership is primarily based in Australia and New Zealand, it now extends to Asia, North America, Europe and the United Kingdom.

Antimicrobials 2015

26 - 28 February 2015

Brisbane Convention and Exhibition Centre

www.antimicrobials2015.com



Latest BREAK POINT Newsletter

  - past newsletters available on the Public Newsletters page

Current Newsletter (members only):

(You must be logged in to view this newsletter.)

  • In the News
  • Sequencing Antibiotic Resistance Plasmids from the Enterobacteriaceae
  • CLSI and EUCAST News
  • Meeting Calendar



Latest ASA News

  - more on the ASA News page

10 Feb 2015
Antimicrobials 2015 Book of Abstracts and Final Program
Antimicrobials 2015
26 - 28 February 2015
Brisbane Convention and Exhibition Centre
 
 
The Final Program and Book of Abstracts for Antimicrobials 2015 is now available in the Members Area of the ASA website
 
A paper copy will be provided to all delegates 
 
Meeting Overview
 
Plenary Speakers
  • Sara Cosgrove, Johns Hopkins University School of Medicine, USA
  • Jan Kluytmans, Erasmus Medical University, The Netherlands
  • Sally Roberts, Auckland City Hospital, New Zealand
  • Gunnar Kahlmeter, Central Hospital, Sweden  
Howard Florey Oration
  • Benjamin Howden Doherty Institute, Victoria.  
Keynote Speakers
  • Jan Kluytmans, University Medical Center in Utrecht, The Netherlands
  • David Persing, Cepheid Holding, USA
  • Christine Ginocchio, Hofstra North Shore-LIJ School of Medicine, New York, USA
  • Neil Clancy, University of Pittsburgh, USA
  • Pattarachai Kiratsin, Sirriraj Hospital Medical Facility, Thailand
 
In addition, the programme’s symposia cover many different aspects on antimicrobials and sessions include “Alternative Perspectives on Antimicrobial Use”, “Carbapenemases”, “What to Report and How to Treat, and “Enterococci".   Two pharmacy symposia, two EUCAST workshop sessions, six proffered papers and two poster sessions are also included in the meeting. 
 
Each morning will commence with a breakfast industry symposium and on Thursday MSD will be hosting a lunch time symposium. 
 
To promote discussion and interaction between delegates and the invited speakers the meeting’s registration includes lunches, morning and afternoon teas and admission to the Howard Florey Reception and the Industry Reception.
 
I would like to take this opportunity to thank all our speakers and sponsors for participating in Antimicrobials 2015 and I am confident delegates will find the meeting’s programme both scientifically stimulating and informative and we look forward to seeing you in Brisbane.
 
Thomas Gottlieb
ASA President
 
17 Jan 2015
Communicable Disease Intelligence Volume 38 Number 4 December 2014
 
 
 
 
 
Communicable Diseases Intelligence Volume 38 Number 4, December 2014

Contents

This issue is available as a full PDF (3620 KB) or by individual articles below.

Annual reports

Australian Meningococcal Surveillance Programme annual report, 2013
Monica M Lahra, Rodney P Enriquez
Full text [HTML] | Full text [PDF 493 KB]
 
Australian Staphylococcus aureus Sepsis Outcome Programme annual report, 2013
Geoffrey W Coombs, Graeme R Nimmo, Denise A Daley, Tam T Le, Julie C Pearson, Hui-Leen Tan, James O Robinson, Peter J Collignon, Mary-Louise McLaws, John D Turnidge for the Australian Group on Antimicrobial Resistance
Full text [HTML] | Full text [PDF 504 KB]
 
Australian Enterococcal Sepsis Outcome Programme annual report, 2013
Geoffrey W Coombs, Julie C Pearson, Denise A Daley, Tam T Le, James O Robinson, Thomas Gottlieb, Benjamin P Howden, Paul DR Johnson, Catherine M Bennett, Timothy P Stinear, John D Turnidge for the Australian Group on Antimicrobial Resistance
Full text [HTML] | Full text [PDF 402 KB]
 
Enterobacteriaceae Sepsis Outcome Programme annual report, 2013
John D Turnidge, Thomas Gottlieb, David H Mitchell, Geoffrey W Coombs, Denise A Daley, Jan M Bell for the Australian Group on Antimicrobial Resistance
Full text [HTML] | Full text [PDF 410 KB]
 
Tuberculosis notifications in Australia, 2011
Christina Bareja, Justin Waring, Richard Stapledon, Cindy Toms, Paul Douglas and the National Tuberculosis Advisory Committee, for the Communicable Diseases Network Australia
Full text [HTML] | Full text [PDF 561 KB]
 
Tuberculosis in Australia: bacteriologically-confirmed cases and drug resistance, 2011
Richard Lumb, Ivan B Bastian, Peter J Jelfs, Terillee J Keehner, Sushil K Pandey, Aina Sievers
Full text [HTML] | Full text [PDF 382 KB]
 
Future reporting of tuberculosis in Australia
Richard Lumb
Full text [HTML] | Full text [PDF 94 KB]

Quarterly reports

National Notifiable Diseases Surveillance System, 1 July to 30 September 2014
Full text [HTML] | Full text [PDF 445 KB]
 
Australian Gonococcal Surveillance Programme, 1 April to 30 June 2014
Monica M Lahra, for the Australian Gonococcal Surveillance Programme
Full text [HTML] | Full text [PDF 235 KB]
 
Meningococcal surveillance Australia, 1 July to 30 September 2014
Monica M Lahra, Rodney Enriquez for the Australian Meningococcal Surveillance Programme
Full text [HTML] | Full text [PDF 189 KB]
 

CDI indexes

Index to Communicable Diseases Intelligence, 2014
Communicable Diseases Intelligence, 2014" href="http://www.health.gov.au/internet/main/publishing.nsf/Content/cda-cdi-index2014.htm">Full text [HTML] | Full text [PDF 342 KB]
 
 
 
 
 
17 Jan 2015
Antimicrobials 2015: BD Breakfast Symposium
Antimicrobials 2015
26 - 28 February 2015
Brisbane Convention and Exhibition Centre
 
 
BD Breakfast Symposium
Friday 27 February 2015
0700 - 0845 
 
The Need for Speed – The Impact of Lab Automation on Clinical Outcomes
Caroline Visser
 
Caroline Visser MD PhD is a clinical microbiologist, head of the Laboratory for Clinical Bacteriology at the Department of Medical Microbiology of the Academic Medical Center (AMC), University of Amsterdam, and member of the AMC Antimicrobial Stewardship committee. As one of the first in the Netherlands, she implemented a TLA platform (BD Kiestra™) in her laboratory in 2009 and has been involved in the further development of various aspects of lab automation since then. These include the use of benchtop digital imaging technology to interact and build microbiology capacity in Vietnamese laboratories (telemicrobiology). In collaboration with Kiestra Lab Automation (now BD), she has been involved in further development and use of automation tools, such as automated colony picking and rapid susceptibility testing. Additional research and development activities include the use of electronic noses (eNose) for the detection of invasive fungal infections and the pathophysiological and diagnostic roles of the respiratory microbiome.
 
 
Online Registration Deadline: www.antimicrobials2015.com
 
13 Jan 2015
ASA Annual General Meeting
All ASA financial members are invited to attend the Society's annual general meeting which will be held during Antimicrobials 2015
 
 Venue:   Boulevard Auditorium
                Brisbane Convention and Exhibition Centre
                Grey Street South Bank Brisbane, Queensland
 
Time:       Friday 27th February 2015. 615PM
 
Agenda:  Members Area Antimicrobials 2015
 
Members unable to attend the annual general meeting may email their apologies to the Society's Secretary Ms Des Kotsanas (info@asainc.net.au)
 
4 Jan 2015
Antimicrobials 2015: ASA Travel Awards
Antimicrobials 2015
26 - 28 February 2015
Brisbane Convention and Exhibition Centre, Brisbane
 
The Australian Society for Antimicrobials (ASA) congratulates the following ASA Members for being awarded an ASA Travel Grant to attend Antimicrobials 2015:
 
Sam Abraham.  Murdoch University, Western Australia, Australia. First detection of extended-spectrum cephalosporin and fluoroquinolone-resistant Escherichia coli in Australian food-producing animals, representing internationally disseminated multidrug-resistant zooanthroponotic clonal lineages
 
Jason Kwong.  University of Melbourne, Victoria, Australia.  Whole genome sequencing indicates local transmission of KPC-2 producing Klebsiella pneumonia in a Victoria-wide outbreak
 
Josh Ramsay.  Curtin University, Western Australia, Australia.  The majority of multidrug-resistance plasmids in Staphylococcus aureus carry origin-of-transfer sequences that are mobilisable by conjugative plasmids
 
During Antimicrobials 2015 over 90 proffered papers will be presented
 
Online registration: www.antimicrobials2015.com
 
30 Dec 2014
Antimicrobials 2015: MSD Lunch Symposium
Antimicrobials 2015
26 - 28 February 2015
Brisbane Convention and Exhibition Centre
 
MSD Lunch Symposium
Thursday 26 February 2015
1330 – 1430
 
Mechanisms of Antifungal Drug Resistance and Susceptibility in Candida Species: Correlations with Therapeutic Efficacy
Neil Clancy
University of Pittsburgh, ID Division
 
 
Dr. Clancy is an Associate Professor of Medicine. His laboratories are interested in the molecular pathogenesis of invasive infections caused by the fungus Candida albicans

Dr. Clancy's labs have implicated several novel genes in both organisms that contribute to the pathogenesis of candidiasis and aspergillosis. Biological processes related to these genes that are studied in the lab include histone methylation and transcriptional regulation, DNA damage responses, and phosphoinositide regulation. 

In addition, he and Dr. Nguyen collaborate on research into mechanisms of antimicrobial resistance in bacteria and fungi and their relevance to treatment efficacy, and on susceptibility to cytomegalovirus infections among transplant recipients.
 
 
28 Dec 2014
Antimicrobials 2015: bioMerieux Breakfast Symposium
Antimicrobials 2015
26 - 28 February 2015
Brisbane Convention and Exhibition Centre
 
bioMerieux Breakfast Symposium
Thursday 26 February 2015
0700 - 0845 
 
Technology’s Transformation of “Real-Time” Diagnosis, Treatment and Surveillance
Christine Ginocchio
 
Christine C. Ginocchio, Ph.D, MT (ASCP) is the VP, Global Microbiology Affairs, bioMérieux, NC and Professor of Medicine, Hofstra North Shore-LIJ School of Medicine, NY. Previously, she was Senior Medical Director and Chief, Division of Infectious Disease Diagnostics, North Shore-LIJ Health System Laboratories, NY. She has 40 years’ experience in Clinical Diagnostics and has been the principal investigator for more than 60 industry and Pharmaceutical clinical trials.  Dr. Ginocchio’s areas of extra-mural funded research have included HIV, CMV, respiratory viruses, HPV, antibiotic resistance and molecular diagnostics for infectious diseases. Her awards include the President’s Award and Irving Abrahams Award for outstanding basic science research, the PASCV 2012 award in Diagnostic Virology and the ASM 2013 BD Award for Research in Clinical Microbiology. She is currently the Co-Editor-in-Chief for the Journal of Clinical Virology. Dr. Ginocchio has published 9 book chapters, over 225 peer-reviewed articles/abstracts and has been an invited speaker at over 200 national and international conferences. 
 
 
Important Dates:
Early Bird Registration Deadline: Friday 2nd January 2015
 
28 Dec 2014
Antimicrobials 2015: Cepheid Breakfast Symposium
Antimicrobials 2015
26 - 28 February 2015
Brisbane Convention and Exhibition Centre
 
 
Cepheid Breakfast Symposium
Saturday 28 February 2015
0700 - 0845 
 
What we can learn from the use of GeneXpert in remote communities – the importance of improving Time to Treatment
David Persing
 
 
Dr. Persing is the Cepheid Executive Vice President and Chief Medical and Technology Officer and Consulting Professor at Stanford University. From 1999 to 2005, Dr. Persing was Senior Vice President and Chief Scientific Officer at Corixa Corporation, a Seattle-based biotechnology company. Prior to that he was a member of the Clinical and Research Faculty in the Department Laboratory Medicine and Pathology at the Mayo Clinic in Rochester, Minnesota where he developed several extramurally funded infectious disease research programs. From 1992 to 1999 he established and directed the Mayo Molecular Microbiology Laboratory which was one of the first reference laboratories to offer cutting-edge molecular diagnostic testing on a worldwide basis. He has authored over 270 peer-reviewed articles including frequently cited papers in the New England Journal of Medicine, Science, and PNAS. He served as Editor in Chief for four leading textbooks on Molecular Diagnostics, the most recent of which was released in January 2011. Dr. Persing received his MD and PhD (Genetics) degrees from the University of California, San Francisco in 1988 and completed his residency training in Clinical Pathology at the Yale School of Medicine in 1990.
 
 
Important Dates:
Early Bird Registration Deadline: Friday 2nd January 2015
 
10 Dec 2014
Antimicrobials 2015: Programme Update
Antimicrobials 2015
26 - 28 February 2015
Brisbane Exhibition and Convention Centre
 
During Antimicrobials 2015 five keynote lectures have been arranged including:
 
Keynote Lecture 1
All E. coli are Equal, but some more Equal than Others: The Success of ST131 in Health Care Settings
Jan Kluytmans, University Medical Center in Utrecht, The Netherlands
 
Keynote Lecture 2
The Digital Miasma: Cloud-based Monitoring of Emerging Infections in the 21st Century
David Persing, Cepheid Holding, USA
 
Keynote Lecture 3
The Impact of Rapid Diagnostics and its Impact on Antibiotic Stewardship
Christine Ginocchio, Hofstra North Shore-LIJ School of Medicine, New York, USA
 
Keynote Lecture 4
Impact of (improved) Diagnostics on the Treatment of Invasive Candidiasis
Neil Clancy, University of Pittsburgh, USA
 
Keynote Lecture 5
Evolving Gram-negative Resistance in Thailand and Implications for Future Patient Care
Pattarachai Kiraitsin, Sirriraj Hospital Medical Facility, Thailand
 
 
Online registration: www.antimicrobials2015.com
 
Abstract Submission Deadline
Friday 12 December 2014
Abstracts must be submitted online at www.antimicrobials2015.com
 
26 Oct 2014
Antimicrobials 2015: Programme Update
Antimicrobials 2015
26 - 27 February 2015
Brisbane Convention and Exhibition Centre
 
 
Programme Update: Keynote Lecture
 
The Digital Miasma: Cloud-based Monitoring of Emerging Infections in the 21st Century
David Persing
 
 
Dr. Persing is the Cepheid Executive Vice President and Chief Medical and Technology Officer and Consulting Professor at Stanford University. From 1999 to 2005, Dr. Persing was Senior Vice President and Chief Scientific Officer at Corixa Corporation, a Seattle-based biotechnology company. Prior to that he was a member of the Clinical and Research Faculty in the Department Laboratory Medicine and Pathology at the Mayo Clinic in Rochester, Minnesota where he developed several extramurally funded infectious disease research programs. From 1992 to 1999 he established and directed the Mayo Molecular Microbiology Laboratory which was one of the first reference laboratories to offer cutting-edge molecular diagnostic testing on a worldwide basis. He has authored over 270 peer-reviewed articles including frequently cited papers in the New England Journal of Medicine, Science, and PNAS. He served as Editor in Chief for four leading textbooks on Molecular Diagnostics, the most recent of which was released in January 2011. Dr. Persing received his MD and PhD (Genetics) degrees from the University of California, San Francisco in 1988 and completed his residency training in Clinical Pathology at the Yale School of Medicine in 1990.
 
Important Dates:
Abstract Submission Deadline: Friday 12th December 2014
Early Bird Registration Deadline: Friday 2nd January 2015
 
30 Jul 2014
Antimicrobials 2015 Meeting Registration Website Open
Antimicrobials 2015
26 - 28 February 2015
Brisbane Exhibition and Convention Centre
 
 
On behalf of the Australian Society for Antimicrobials I would like to invite you to the Society’s 16th Annual Scientific Meeting “Antimicrobials 2015” to be held at the Brisbane Exhibition and Convention Centre, Brisbane, on Thursday 26th - Saturday 28nd February 2015.
 
I am pleased to announce Sara Cosgrove, Johns Hopkins University School of Medicine, USA; Jan Kluytmans, Erasmus Medical University, The Netherlands; Sally Roberts, Auckland City Hospital, New Zealand; and Gunnar Kahlmeter, Central Hospital, Sweden will be participating at the meeting.  Sara will be presenting the plenary “Multiple Prongs of Stewardship: Less is More – Debunking Stewardship Myths”, while Jan and Sally will be presenting “Resistance Links to Animals" and “Improving Care: Infection Prevention and Patient Safety” respectively. In addition to presenting the plenary “EUCAST and Beyond”, Gunnar with Erika Matusckek will be presenting two EUCAST workshops on susceptibility testing.  
 
The 2015 Howard Florey Oration will be delivered by Benjamin Howden from Melbourne University, Victoria.  Ben will be presenting the talk “Vancomycin and Staphylococcus aureus – A Complex Relationship”
 
 The programme’s symposia cover many different aspects on antimicrobials and sessions include “Alternative Perspectives on Antimicrobial Use”, “Carbapenemases”, “What to Report and How to Treat”, “Enterococci" and "SMART Platforms”.   In addition we have two pharmacy symposia on Saturday afternoon titled “The Bugs and Treatment” and "Antimicrobial Stewardship". Six proffered papers and two poster sessions are also planned for the meeting.
 
To promote discussion and interaction between delegates and the invited speakers the meeting’s registration includes lunches, morning and afternoon teas and admission to the Howard Florey Reception and the Industry Reception. I am confident that you will find the meeting’s programme both scientifically stimulating and informative and we look forward to meeting you in Brisbane.
 
Important Dates
 
Abstract Submission Deadline: Friday 12th December 2014
 
Early Bird Registration Deadline: Friday 2nd January 2015
 
 
 
Thomas Gottlieb
President ASA